SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Geriatric Psychiatry and Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hoyer, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hoyer, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Brain Oxidative Energy and Related Metabolism, Neuronal Stress, and Alzheimer's Disease: A Speculative Synthesis

Siegfried Hoyer, MD

Department of Pathochemistry and General Neuro-chemistry, Universität of Heidelberg, Heidelberg, FRG.

A reduction in the cerebral metabolic rate of glucose is one of the most predominant abnormalities generally found in the Alzheimer brain, whereas the cerebral metabolic rate of oxygen is diminished only slightly or not at all at the beginning of this dementive disorder. From the cerebral metabolic rates of oxidized glucose and oxygen, the cerebral adenosine triphosphate (ATP) formation rate was calculated in incipient early-onset, incipient late-onset, and stable advanced dementia of the Alzheimer type (DAT). A reduction in ATP formation by various amounts was found, ranging from at least 7% in incipient early-onset DAT, from around 20% in incipient late-onset DAT, and from 35% up to more than 50% in stable advanced dementia. The cerebral diminution in energy availability, along with a loss of functionally important amino acids, ammonia toxicity, supposed membrane damage, dysregulation of Ca2+ homeostasis, and glycogen accumulation in the incipient stages of DAT are assumed to be stress-related abnormalities capable of inducing the formation of heat shock proteins. These events may lead to an enhanced generation of amyloid precursor protein in earlier states of DAT. If abnormally cleaved, amyloid A4 protein may be produced in increased amounts. From the results discussed in this article it is deduced as a speculative synthesis that perturbations in brain oxidative energy and related metabolism may precede the generation of amyloid precursor protein and the formation of plaques in the brain affected by incipient DAT. (J Geriatr Psychiatry Neurol 1993;1:3–13).

Journal of Geriatric Psychiatry and Neurology, Vol. 6, No. 1, 3-13 (1993)
DOI: 10.1177/002383099300600101


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
P. W. Schofield, G. Logroscino, H. F. Andrews, S. Albert, and Y. Stern
An association between head circumference and Alzheimer's disease in a population-based study of aging and dementia
Neurology, July 1, 1997; 49(1): 30 - 37.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. M. Albert, M. Sano, K. Marder, D. M. Jacobs, J. Brandt, M. Albert, and Y. Stern
Participation in clinical trials and long-term outcomes in Alzheimer's disease
Neurology, July 1, 1997; 49(1): 38 - 43.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. D. Parker Jr. and J. K. Parks
Cytochrome C Oxidase in Alzheimer's Disease Brain: Purification and Characterization
Neurology, March 1, 1995; 45(3): 482 - 486.
[Abstract] [Full Text] [PDF]



Advertisement